| Literature DB >> 17303196 |
Andrea C Solomon1, Julie C Stout, Shannon A Johnson, Douglas R Langbehn, Elizabeth H Aylward, Jason Brandt, Christopher A Ross, Leigh Beglinger, Michael R Hayden, Karl Kieburtz, Elise Kayson, Elaine Julian-Baros, Kevin Duff, Mark Guttman, Martha Nance, David Oakes, Ira Shoulson, Elizabeth Penziner, Jane S Paulsen.
Abstract
Previous studies of verbal episodic memory in pre-diagnostic Huntington's disease (HD) have yielded mixed results; some evidence suggests that memory decline is evident prior to the onset of pronounced neurological signs of HD, whereas other data indicate that memory function remains normal throughout the pre-diagnostic period. This study examines verbal episodic memory in a sample of CAG expanded individuals who have not yet been clinically diagnosed, and who represent a wide range of points along the continuum from health to disease. The Hopkins Verbal Learning Test-Revised (HVLT-R) was administered to 479 participants (428 with the HD CAG expansion and 51 without), and performance was compared to neurobiological indices of disease progression, including a DNA-based estimate of proximity to clinical diagnosis, magnetic resonance imaging (MRI) measures of striatal volume, and neurologist ratings of motor signs. Lower HVLT-R scores were associated with closer proximity to clinical diagnosis and smaller striatal volumes; these relationships were found even in groups with no neurological signs of HD. The CAG expanded groups, including those with only minimal neurological signs, had significantly lower HVLT-R scores than the control group, and performance was worse in sub-groups that had more neurological signs consistent with HD. These findings indicate that verbal episodic memory is affected in early pre-diagnostic HD and may decline as striatal volumes decrease and individuals approach the motor diagnostic threshold.Entities:
Mesh:
Year: 2007 PMID: 17303196 PMCID: PMC2570315 DOI: 10.1016/j.neuropsychologia.2006.12.015
Source DB: PubMed Journal: Neuropsychologia ISSN: 0028-3932 Impact factor: 3.139